Overview
Addy Palomino practices practicing medicine in Sao Paulo, Brazil.
Their clinical expertise encompasses Infantile Pneumothorax, Anal Cancer, Lymphofollicular Hyperplasia, and Endoscopy.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Addy M. Palomino
Is Addy M. Palomino a top-rated expert for Endoscopy?
MediFind is an objective health platform that identifies experts based on real-world data. Addy M. Palomino is classified as an Experienced expert for Endoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Addy M. Palomino participate in research or clinical trials?
Yes. Addy M. Palomino has published 14 articles and abstracts on conditions like Endoscopy. You can view a list of Addy M. Palomino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerPalomino isExperienced. Learn about Anal Cancer.
- EndoscopyPalomino isExperienced. Learn about Endoscopy.
- Infantile PneumothoraxPalomino isExperienced. Learn about Infantile Pneumothorax.
- Lymphofollicular HyperplasiaPalomino isExperienced. Learn about Lymphofollicular Hyperplasia.